ahlam1399
07-08-2015, 02:26 AM
**vartis wins early FDA approval for new heart failure drug
(Reuters) - **vartis AG on Tuesday won U.S. approval for its keenly awaited new heart failure drug Entresto earlier than expected, boosting hopes for a medicine tipped by analysts to reap billions of dollars in annual sales.
http://rc.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/rc/1/rc.img (http://rc.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/rc/1/rc.htm)
http://rc.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/rc/2/rc.img (http://rc.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/rc/2/rc.htm)
http://rc.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/rc/3/rc.img (http://rc.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/rc/3/rc.htm)
http://da.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/a2.img (http://da.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/a2.htm)
http://adchoice.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/ach.img (http://adchoice.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/ach.htm)http://pi.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/a2t.imghttp://pi2.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/47eb87f3/sc/32/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=gk3mg7m_V_8:TgbVrfd-zvY:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=gk3mg7m_V_8:TgbVrfd-zvY:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=gk3mg7m_V_8:TgbVrfd-zvY:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=gk3mg7m_V_8:TgbVrfd-zvY:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=gk3mg7m_V_8:TgbVrfd-zvY:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/gk3mg7m_V_8
(Reuters) - **vartis AG on Tuesday won U.S. approval for its keenly awaited new heart failure drug Entresto earlier than expected, boosting hopes for a medicine tipped by analysts to reap billions of dollars in annual sales.
http://rc.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/rc/1/rc.img (http://rc.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/rc/1/rc.htm)
http://rc.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/rc/2/rc.img (http://rc.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/rc/2/rc.htm)
http://rc.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/rc/3/rc.img (http://rc.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/rc/3/rc.htm)
http://da.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/a2.img (http://da.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/a2.htm)
http://adchoice.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/ach.img (http://adchoice.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/ach.htm)http://pi.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/a2t.imghttp://pi2.feedsportal.com/r/233194384656/u/49/f/654207/c/35217/s/47eb87f3/sc/32/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/47eb87f3/sc/32/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=gk3mg7m_V_8:TgbVrfd-zvY:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=gk3mg7m_V_8:TgbVrfd-zvY:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=gk3mg7m_V_8:TgbVrfd-zvY:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=gk3mg7m_V_8:TgbVrfd-zvY:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=gk3mg7m_V_8:TgbVrfd-zvY:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/gk3mg7m_V_8